Almost 10% of epithelial ovarian cancer cases are associated with dominant genetic predisposition, in most cases (80 – 90%), linked to mutations in BRCA1 or BRCA2 [4-6]. The gene discussed is BRCA2; the disease is ovarian carcinoma.